Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,212 | 52 | 71.5% |
| Current or prospective ownership or investment interest | $872.37 | 7 | 28.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10.76 | 1 | 0.3% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $872.37 | 15 | $0 (2024) |
| Horizon Therapeutics plc | $441.93 | 6 | $0 (2023) |
| Amgen Inc. | $337.23 | 11 | $0 (2024) |
| Alcon Vision LLC | $311.97 | 12 | $0 (2024) |
| Alcon Laboratories Inc | $151.93 | 2 | $0 (2017) |
| NEW WORLD MEDICAL,INC. | $132.23 | 1 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $125.47 | 3 | $0 (2024) |
| Omeros Corporation | $125.00 | 1 | $0 (2019) |
| Shire North American Group Inc | $122.06 | 1 | $0 (2017) |
| Johnson & Johnson Surgical Vision, Inc. | $109.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $675.59 | 19 | Amgen Inc. ($337.23) |
| 2023 | $401.57 | 10 | Horizon Therapeutics plc ($316.33) |
| 2022 | $594.94 | 16 | US Retina LLC ($358.42) |
| 2021 | $171.74 | 3 | US Retina LLC ($171.74) |
| 2020 | $252.22 | 4 | Horizon Therapeutics plc ($125.60) |
| 2019 | $476.88 | 8 | US Retina LLC ($172.27) |
| 2018 | $138.07 | 3 | Aerie Pharmaceuticals, Inc. ($79.25) |
| 2017 | $383.92 | 5 | Alcon Laboratories Inc ($151.93) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $132.23 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $55.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/26/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: OPTOMETRY | ||||||
| 09/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/18/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $121.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $66.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $43.34 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $43.60 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 2024 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/21/2023 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Ophthalmology | ||||||
| 12/19/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: TEPEZZA | ||||||
| 08/29/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: TEPEZZA | ||||||
| 07/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: TEPEZZA | ||||||
| 07/24/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.10 | General |
| 05/02/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 765 | 2,840 | $250,061 | $85,675 |
| 2022 | 16 | 843 | 3,230 | $268,109 | $84,196 |
| 2021 | 19 | 924 | 3,966 | $278,407 | $98,671 |
| 2020 | 19 | 1,005 | 3,388 | $342,210 | $106,766 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 247 | $51,129 | $20,404 | 39.9% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Office | 2023 | 19 | 19 | $26,600 | $12,050 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 176 | $24,640 | $10,853 | 44.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 1,995 | $25,935 | $9,760 | 37.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 13 | 17 | $39,950 | $7,052 | 17.7% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 11 | 11 | $15,400 | $6,979 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $13,038 | $4,584 | 35.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 11 | 39 | $13,455 | $4,192 | 31.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 49 | 49 | $11,760 | $3,270 | 27.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 25 | 27 | $4,401 | $1,242 | 28.2% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 22 | 25 | $3,375 | $1,168 | 34.6% |
| 92285 | Photography of content of eyes | Office | 2023 | 69 | 71 | $6,035 | $1,110 | 18.4% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 52 | 53 | $5,830 | $1,083 | 18.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 31 | 34 | $3,706 | $833.83 | 22.5% |
| 92134 | Imaging of retina | Office | 2023 | 18 | 20 | $2,180 | $600.45 | 27.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 15 | 16 | $2,627 | $494.83 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 284 | $58,788 | $23,116 | 39.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 17 | 2,300 | $29,900 | $11,126 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 167 | $23,380 | $9,687 | 41.4% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 17 | 17 | $23,800 | $9,418 | 39.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 18 | 23 | $54,050 | $9,321 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $13,674 | $5,011 | 36.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 18 | 47 | $16,215 | $4,928 | 30.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 52 | 52 | $12,480 | $3,111 | 24.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 38 | 40 | $6,520 | $1,621 | 24.9% |
About Dr. Mark Malton, MD
Dr. Mark Malton, MD is a Neuro-ophthalmology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629068283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Malton, MD has received a total of $3,095 in payments from pharmaceutical and medical device companies, with $675.59 received in 2024. These payments were reported across 68 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,212).
As a Medicare-enrolled provider, Malton has provided services to 3,537 Medicare beneficiaries, totaling 13,424 services with total Medicare billing of $375,308. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Neuro-ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery, Ophthalmology
- Location Charlotte, NC
- Active Since 10/25/2005
- Last Updated 02/23/2023
- Taxonomy Code 207WX0109X
- Entity Type Individual
- NPI Number 1629068283
Products in Payments
- TEPEZZA (Drug) $441.93
- TEPEZZA (Biological) $337.23
- XIIDRA (Drug) $175.60
- Kahook Dual Blade (Device) $132.23
- PanOptix (Device) $130.74
- NGENUITY (Device) $126.13
- XDEMVY (Drug) $125.47
- OMIDRIA (Drug) $125.00
- Tecnis 1-piece IOL (Device) $109.93
- Rhopressa (Drug) $101.91
- Clareon (Device) $101.48
- VYZULTA (Drug) $42.86
- VEVYE (Drug) $34.49
- ReSTOR (Device) $25.80
- RXSIGHT CONTACT LENS (Device) $21.34
- BOTOX (Biological) $20.04
- Xeomin (Biological) $19.82
- ARGOS (Device) $19.71
- LenSx (Device) $19.69
- INVELTYS (Drug) $15.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.